Bio Blast Pharma - 48 Year Dividend History | ENLV

Historical dividend payout and yield for Bio Blast Pharma (ENLV) since 1971. The current TTM dividend payout for Bio Blast Pharma (ENLV) as of November 19, 2019 is $0.00. The current dividend yield for Bio Blast Pharma as of November 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.083B $0.000B
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Stock Name Country Market Cap PE Ratio